CH

Christoph Hock

UZ Universität Zürich: 11 patents #1 of 243Top 1%
BG Biogen International Neuroscience Gmbh: 9 patents #2 of 19Top 15%
UZ Universitat Zurich: 8 patents #6 of 394Top 2%
NA Neurimmune Holding Ag: 3 patents #5 of 19Top 30%
MI Morton International: 1 patents #302 of 580Top 55%
BO BOE: 1 patents #7,844 of 12,373Top 65%
📍 Küsnacht (ZH), UT: #1 of 1 inventorsTop 100%
Overall (All Time): #206,629 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
11352441 Human anti-SOD1 antibodies Fabio Montrasio, Maria Grazia Barenco Montrasio, Jan Grimm, Roger Nitsch, Tobias Welt +2 more 2022-06-07
11091540 TDP-43 specific binding molecules Roger Nitsch, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jan Grimm, Jean-Luc Baeriswyl +3 more 2021-08-17
10703808 Human anti-alpha-synuclein antibodies Andreas Weihofen, Jan Grimm, Roger Nitsch 2020-07-07
10344097 Human anti-SOD1 antibodies Fabio Montrasio, Maria Grazia Barenco Montrasio, Jan Grimm, Roger Nitsch, Tobias Welt +2 more 2019-07-09
10301381 Anti-alpha synuclein binding molecules Andreas Weihofen, Jan Grimm, Roger Nitsch, Lihe Su, Paul H. Weinreb 2019-05-28
10259866 TDP-43 specific binding molecules Roger Nitsch, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jan Grimm, Jean-Luc Baeriswyl +3 more 2019-04-16
10202445 Method of providing disease-specific binding molecules and targets Roger Nitsch, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2019-02-12
10131708 Methods of treating Alzheimer's disease Roger Nitsch, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2018-11-20
9975947 Anti-alpha synuclein binding molecules Andreas Weihofen, Jan Grimm, Roger Nitsch, Lihe Su, Paul H. Weinreb 2018-05-22
9896504 Human anti-alpha-synuclein antibodies Andreas Weihofen, Jan Grimm, Roger Nitsch 2018-02-20
9828420 Method of providing disease-specific binding molecules and targets Roger Nitsch, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2017-11-28
9670272 Method of providing disease-specific binding molecules and targets Roger Nitsch, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2017-06-06
9605059 Human anti-tau antibodies Roger Nitsch, Feng Chen, Jan Grimm, Jean-Luc Baeriswyl 2017-03-28
9587014 TDP-43 specific binding molecules Roger Nitsch, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jan Grimm, Jean-Luc Baeriswyl +3 more 2017-03-07
9580493 Anti-α synuclein binding molecules Andreas Weihofen, Jan Grimm, Roger Nitsch, Lihe Su, Paul H. Weinreb 2017-02-28
9283271 Human anti-SOD1 antibodies Fabio Montrasio, Maria Grazia Barenco Montrasio, Jan Grimm, Roger Nitsch, Marcel Maier 2016-03-15
8940272 Human anti-tau antibodies Roger Nitsch, Feng Chen, Jan Grimm, Jean-Luc Baeriswyl 2015-01-27
8940276 Human anti-alpha-synuclein antibodies Andreas Weihofen, Jan Grimm, Roger Nitsch 2015-01-27
8906367 Method of providing disease-specific binding molecules and targets Roger Nitsch, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm 2014-12-09
6573276 Muscarinic M1 agonist as an inhibitor of beta-amyloid (A&bgr;40 and A&bgr;42)-synthesis Andreas Raschig, Marion Wienrich, Roger Nitsch, Klaus Mendla, Dieter Meier +2 more 2003-06-03
5368329 Dual stage inflator 1994-11-29